Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-05

Clinical Trial Update: Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing three new nicotine gum formulations with a reference gum has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine gum formulation 1 (nicotine gum)
  • Nicotine gum formulation 2 (nicotine gum)
  • Nicotine gum formulation 3 (nicotine gum)
  • Reference nicotine gum (nicotine gum)

Snippet

Sponsor: Fertin Pharma A/S | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED